Global Nano-drug Market Type (Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, Microemulsion and Nanoemulsion, Nanosuspension) Application (Cancer and Tumors, Autoimmune Disorders) - Global Trends and Forecasts to 2025
Industry Insights
The Global Nano-drug Market is expected to grow at a CAGR of XX % during the forecast period 2018-2025.
The Global Nano-drug Market is segmented on the basis of Type and Application. The Global Nano-drug Market is segmented based on the basis of type Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, Microemulsion and Nanoemulsion, Nanosuspension. By Application, it is classified as Cancer and Tumors, Autoimmune Disorders. The regional outlook on the Global Nano-drug Market covers regions, such as North America, Europe, Asia-Pacific, and Rest of the World. Global Nano-drug Market for each region is further bifurcated for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Report Scope:
The Global Nano-drug Market report scope covers the in-depth business analysis considering major market dynamics, forecast parameters, and price trends for the industry growth. The report forecasts market sizing at global, regional and country levels, providing comprehensive outlook of industry trends in each market segments and sub-segments from 2017 to 2024. The market segmentations include
Global Nano-drug Market, By Type
Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, Microemulsion and Nanoemulsion, Nanosuspension
In the same way, the study has divided by applications
Global Nano-drug Market, By Application
Cancer and Tumors, Autoimmune Disorders
Global Nano-drug Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
The report scope also includes competitive landscape covering the competitive analysis, strategy analysis and company profiles of the major market players. The companies profiled in the report include Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy
Report Highlights
- Global Nano-drug Market sizes from 2017 to 2024
- Market growth projections through 2024 and the resultant market forecast for 2024
- Impact of the market dynamics including market drivers, restraints and opportunities in the market size
- Key industry trends, product trends, and application trends
- Major driving/ leading segmentations, regions and countries in the Global Nano-drug Market
- Competitive analysis with comprehensive company profiles of the leading industry players
- In-depth analysis on growth and expansion strategies adopted by market players and their resulting effect on market growth and competition
How this report will add value to your organisation
This report provides the in-depth analysis of the complete value chain from the raw material suppliers to the end users. We have critically analysed following parameters and their impact in the industry:
1. Improvement in top line and bottom line growth
Analysis trend & forecasts by end use markets will help you to understand how the growth in consumption is expected in next 5 years and what will be the key factors that will support the growth. This will help to make a clear plan for the top line growth. Price analytics will also play a crucial role in making a plan for top line growth.
Raw material and other input factors analysis will help to plan effectively for the bottom line.
2. Competitive intelligence
In a competitive marketplace, up-to-date information can make the difference between keeping pace, getting ahead, or being left behind. A smart intelligence operation can serve as an early-warning system for disruptive changes in the competitive landscape, whether that change is a rival's new product or pricing strategy or the entrance of an unexpected player into your market.
We also provide you with information that allows you to anticipate what your competitors are planning next. For example, you might gain information on a new product they are getting ready to launch or new services they will add to the business. Hiring us to handle this information collection saves you time and energy, allowing you to focus on your own business while still gaining the necessary knowledge to keep track of competitors.
3. Identification of prospective customers and their satisfaction level with the current supplier:
We have provided the long list of customers and analysed them critically, based on various parameters such as consumption, market type, sustainable business etc. this will help your organisation to develop relations with the consumers. Also, we have identified the factors in which the others customer will switch to you.
Report Customizations
The customization research services cover the additional custom report features such as additional regional and country level analysis as per the client requirements.
Table of Contents
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Porter's Five Force Analysis
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
5. Global Nano-drug Market, By Type
5.1 Introduction
5.2 Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, Microemulsion and Nanoemulsion, Nanosuspension
5.2.1 Market Overview
5.2.2 Market Size and Forecast
6. Global Nano-drug Market, By Application
6.1 Introduction
6.2 Cancer and Tumors, Autoimmune Disorders
6.2.1 Market Overview
6.2.2 Market Size and Forecast
7. Global Nano-drug Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Nano-drug Market, By Type
7.2.2 North America Nano-drug Market, By Application
7.3 Europe
7.3.1 Europe Nano-drug Market, By Type
7.3.2 Europe Nano-drug Market, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Nano-drug Market, By Type
7.4.2 Asia-Pacific Nano-drug Market, By Application
7.5 Rest of the World
7.5.1 Rest of the World Nano-drug Market Drugs, By Type
7.5.2 Rest of the World Nano-drug Market, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy
TABLE 1 Nano-drug Market KEY MARKET SEGMENTS IN THIS STUDY 16
TABLE 2 KEY MANUFACTURERS Nano-drug Market COVERED IN THIS STUDY 16
TABLE 3 GLOBAL Nano-drug Market MARKET SIZE GROWTH RATE BY TYPE (2018-2025) (MILLION UNITS) & (MILLION US$) 17
TABLE 4 GLOBAL Nano-drug Market MARKET SIZE GROWTH RATE BY APPLICATION (2018-2025) (MILLION UNITS) 20
TABLE 5 GLOBAL Nano-drug Market CONSUMPTION MARKET SHARE BY APPLICATION IN 2017 20
TABLE 6 GLOBAL Nano-drug Market MARKET SIZE GROWTH RATE BY REGIONS 2018-2025(MILLION UNITS) & (MILLION USD) 24
TABLE 7 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO (CR5 AND HHI) 24
TABLE 8 Nano-drug Market MANUFACTURING BASE DISTRIBUTION AND HEADQUARTERS) 25
TABLE 9 MANUFACTURERS Nano-drug Market PRODUCT OFFERED 25
TABLE 10 DATE OF MANUFACTURERS ENTER INTO Nano-drug Market MARKET 26
TABLE 11 KEY TRENDS FOR Nano-drug Market MARKETS & PRODUCTS 26
TABLE 12 GLOBAL Nano-drug Market PRODUCTION BY MANUFACTURERS (2013-2018) (MILLION UNITS) 27
TABLE 13 GLOBAL Nano-drug Market PRODUCTION SHARE BY MANUFACTURERS (2013-2018) 27
TABLE 14 Nano-drug Market REVENUE BY MANUFACTURERS (2013-2018) (MILLION USD) 28
TABLE 15 Nano-drug Market REVENUE SHARE BY MANUFACTURERS (2013-2018) 29
TABLE 16 MERGERS & ACQUISITIONS, EXPANSION PLANS 29
TABLE 17 GLOBAL Nano-drug Market PRODUCTION BY REGIONS 2013-2018 (MILLION UNITS) 30
TABLE 18 GLOBAL Nano-drug Market PRODUCTION MARKET SHARE BY REGIONS 2013-2018 30
TABLE 19 GLOBAL Nano-drug Market REVENUE BY REGIONS 2013-2018 (MILLION USD) 32
TABLE 20 GLOBAL Nano-drug Market REVENUE MARKET SHARE BY REGIONS 2013-2018 32
TABLE 21 UNITED STATES Nano-drug Market IMPORT & EXPORT (MILLION UNITS) 35
TABLE 22 EUROPE Nano-drug Market IMPORT & EXPORT 37
TABLE 23 CHINA Nano-drug Market IMPORT & EXPORT 39
TABLE 24 JAPAN Nano-drug Market IMPORT & EXPORT 41
TABLE 25 SOUTH KOREA Nano-drug Market IMPORT & EXPORT 43
TABLE 26 GLOBAL Nano-drug Market CONSUMPTION BY REGIONS 2013-2018 (MILLION UNITS) 44
TABLE 27 GLOBAL Nano-drug Market CONSUMPTION MARKET SHARE BY REGION 2013-2018 44
TABLE 28 UNITED STATES Nano-drug Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 46
TABLE 29 UNITED STATES Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 47
TABLE 30 EUROPE Nano-drug Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 49
TABLE 31 EUROPE Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 49
TABLE 32 CHINA Nano-drug Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 51
TABLE 33 CHINA Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 51
TABLE 34 JAPAN Nano-drug Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 53
TABLE 35 JAPAN Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 53
TABLE 36 SOUTH KOREA Nano-drug Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 55
TABLE 39 SOUTH KOREA Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 55
TABLE 40 GLOBAL Nano-drug Market PRODUCTION BY TYPE (2013-2018) (MILLION UNITS) 57
TABLE 41 GLOBAL Nano-drug Market PRODUCTION SHARE BY TYPE (2013-2018) 57
TABLE 42 GLOBAL Nano-drug Market REVENUE BY TYPE (2013-2018) (MILLION USD) 59
TABLE 43 GLOBAL Nano-drug Market REVENUE SHARE BY TYPE (2013-2018) 59
TABLE 44 Nano-drug Market PRICE BY SMART LENSES013-2018 (USD/UNIT) 61
TABLE 45 GLOBAL Nano-drug Market CONSUMPTION BY APPLICATION (2013-2025) (MILLION UNITS) 62
TABLE 46 GLOBAL Nano-drug Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 62
TABLE 47 GLOBAL Nano-drug Market CONSUMPTION SHARE BY APPLICATION (2013-2018) 63
TABLE 48 COMPANY 1 COMPANY DETAILS 64
TABLE 49 COMPANY 1 DESCRIPTION AND BUSINESS OVERVIEW 64
TABLE 50 COMPANY 1 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 65
TABLE 52 COMPANY 1 Nano-drug Market PRODUCT 65
TABLE 53 COMPANY 2 RECENT DEVELOPMENT 65
TABLE 54 COMPANY 2 COMPANY DETAILS 66
TABLE 55 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 66
TABLE 56 COMPANY 3 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 67
TABLE 57 COMPANY 3 Nano-drug Market PRODUCT 67
TABLE 58 COMPANY 3 RECENT DEVELOPMENT 67
TABLE 59 COMPANY 3 COMPANY DETAILS 68
TABLE 60 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 68
TABLE 61 COMPANY 3 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 69
TABLE 62 COMPANY 3 Nano-drug Market PRODUCT 69
TABLE 63 COMPANY 3 RECENT DEVELOPMENT 70
TABLE 64 COMPANY 4 COMPANY DETAILS 71
TABLE 65 COMPANY 4 DESCRIPTION AND BUSINESS OVERVIEW 71
TABLE 66 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 72
TABLE 67 COMPANY 4 Nano-drug Market PRODUCT 72
TABLE 68 COMPANY 4 RECENT DEVELOPMENT 73
TABLE 69 COMPANY 5 OPTICAL COMPANY DETAILS 73
TABLE 70 COMPANY 5 DESCRIPTION AND BUSINESS OVERVIEW 74
TABLE 71 COMPANY5 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 74
TABLE 72 COMPANY 5 OPTICAL Nano-drug Market PRODUCT 74
TABLE 73 COMPANY 5 OPTICAL RECENT DEVELOPMENT 74
TABLE 74 COMPANY 6 COMPANY DETAILS 75
TABLE 75 COMPANY 6 DESCRIPTION AND BUSINESS OVERVIEW 75
TABLE 76 COMPANY 6 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 76
TABLE 77 COMPANY 6 Nano-drug Market PRODUCT 76
TABLE 78 COMPANY 7 GLOBAL COMPANY DETAILS 77
TABLE 79 COMPANY 7 DESCRIPTION AND BUSINESS OVERVIEW 77
TABLE 80 COMPANY 7 GLOBAL Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 77
TABLE 81 COMPANY 7 GLOBAL Nano-drug Market PRODUCT 78
TABLE 82 COMPANY 8 VISION COMPANY DETAILS 79
TABLE 83 COMPANY 8 DESCRIPTION AND BUSINESS OVERVIEW 79
TABLE 84 COMPANY 8 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 80
TABLE 85 COMPANY 8 Nano-drug Market PRODUCT 80
TABLE 86 COMPANY 9 COMPANY DETAILS 81
TABLE 87 COMPANY 9 DESCRIPTION AND BUSINESS OVERVIEW 81
TABLE 88 COMPANY 9 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 81
TABLE 89 COMPANY 9 Nano-drug Market PRODUCT 82
TABLE 90 COMPANY 10 COMPANY DETAILS 83
TABLE 91 COMPANY 10 DESCRIPTION AND BUSINESS OVERVIEW 83
TABLE 92 COMPANY 10 Nano-drug Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 83
TABLE 93 COMPANY 10 Nano-drug Market PRODUCT 84
TABLE 94 GLOBAL Nano-drug Market REVENUE FORECAST BY REGIONS 2018-2025 (MILLION USD) 86
TABLE 95 GLOBAL Nano-drug Market PRODUCTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 87
TABLE 96 GLOBAL Nano-drug Market PRODUCTION FORECAST BY TYPE (2018-2025) (MILLION UNITS) 94
TABLE 97 Nano-drug Market REVENUE FORECAST BY TYPE (2018-2025) (MILLION USD) 95
TABLE 98 GLOBAL Nano-drug Market CONSUMPTION FORECAST BY APPLICATION (2018-2025) (MILLION UNITS) 96
TABLE 99 GLOBAL Nano-drug Market CONSUMPTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 97
TABLE 100 Nano-drug Market DISTRIBUTORS LIST 103
TABLE 101 KEY OPPORTUNITIES AND DRIVERS 104
TABLE 102 KEY CHALLENGES 104
TABLE 103 MARKET RISKS 104
TABLE 104 RESEARCH PROGRAMS/DESIGN FOR THIS REPORT 108
TABLE 105 KEY DATA INFORMATION FROM SECONDARY SOURCES 112
TABLE 106 KEY DATA INFORMATION FROM PRIMARY SOURCES 113
